59 related articles for article (PubMed ID: 2896176)
21. [Subcutaneous long-term pulsatile administration of LH-RH to patients with hypothalamic amenorrhea].
Mizunuma H; Obara M; Yamada K; Ibuki Y; Igarashi M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):933-9. PubMed ID: 3525703
[TBL] [Abstract][Full Text] [Related]
22. [The effects of intranasal application of low dose buserelin in women with hypothalamic amenorrhea].
Takeuchi H; Okabe C; Iida M; Fukuda M; Takada M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):167-73. PubMed ID: 1545170
[TBL] [Abstract][Full Text] [Related]
23. Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception.
Jesam C; Salvatierra AM; Schwartz JL; Croxatto HB
Hum Reprod; 2010 Feb; 25(2):368-73. PubMed ID: 19933235
[TBL] [Abstract][Full Text] [Related]
24. Follicular monitoring and outcome of in vitro fertilization in gonadotropin-releasing hormone-agonist-treated cycles.
Forman RG; Robinson J; Egan D; Ross C; Gosden B; Barlow DH
Fertil Steril; 1991 Mar; 55(3):567-73. PubMed ID: 1900482
[TBL] [Abstract][Full Text] [Related]
25. Gonadal and pituitary responses to progesterone antagonist ZK 98.299 during the follicular phase of the menstrual cycle in bonnet monkeys.
Puri CP; Patil RK; Elger WA; Vadigoppula AD; Jagan MR
Contraception; 1989 Feb; 39(2):227-43. PubMed ID: 2706991
[TBL] [Abstract][Full Text] [Related]
26. Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist.
Lemay A; Quesnel G
Fertil Steril; 1982 Sep; 38(3):376-9. PubMed ID: 6214431
[TBL] [Abstract][Full Text] [Related]
27. Long-term suppression of ovarian function by a luteinizing-hormone releasing hormone agonist implant in patients with endometriosis.
Fraser HM; Sandow J; Cowen GM; Lumsden MA; Haining R; Smith SK
Fertil Steril; 1990 Jan; 53(1):61-8. PubMed ID: 2104808
[TBL] [Abstract][Full Text] [Related]
28. Impaired follicular growth and abnormal luteinizing hormone surge in luteal phase defect.
Ayabe T; Tsutsumi O; Momoeda M; Yano T; Mitsuhashi N; Taketani Y
Fertil Steril; 1994 Apr; 61(4):652-6. PubMed ID: 8150106
[TBL] [Abstract][Full Text] [Related]
29. [The evaluation of serum estradiol, progesterone, testosterone concentrations and urinary estrogen excretion level for the monitoring indices of follicular maturation].
Uehara S; Naganuma T; Chida S; Yohkaichiya T; Tsuiki A; Kyohno K; Mori R; Imaizumi H; Hoshiai H; Suzuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1849-58. PubMed ID: 4056533
[TBL] [Abstract][Full Text] [Related]
30. Morphological studies of human endometrium during continuous LH-RH agonist treatment.
Lundkvist O; Bergquist C
Int J Fertil; 1986; 30(4):65-70. PubMed ID: 2890599
[TBL] [Abstract][Full Text] [Related]
31. Cyclic administration of an LHRH analogue and of progesterone in risk patients to oral contraceptives.
Geisthoevel F; Jenne D; Wieacker P; Breckwoldt M
Contraception; 1987 Oct; 36(4):459-69. PubMed ID: 3127113
[TBL] [Abstract][Full Text] [Related]
32. Reproductive endocrine effects of intranasal administration of norethisterone to adult female rhesus monkeys (Macaca mulatta).
Puri V; David GF; Dubey AK; Puri CP; Anand Kumar TC
J Reprod Fertil; 1986 Jan; 76(1):215-20. PubMed ID: 3944792
[TBL] [Abstract][Full Text] [Related]
33. Endocrine changes following pituitary desensitization with LHRH agonist and administration of purified FSH to induce follicular maturation.
Shaw RW; Ndukwe G; Imoedemhe DA; Bernard A; Burford G; Bentick B
Br J Obstet Gynaecol; 1987 Jul; 94(7):682-6. PubMed ID: 3113476
[TBL] [Abstract][Full Text] [Related]
34. Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase.
Lemay A; Sandow J; Bureau M; Maheux R; Fontaine JY; Mérat P
Fertil Steril; 1988 Mar; 49(3):410-7. PubMed ID: 3125068
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin releasing hormone analogs for female contraception by inhibition of ovulation.
Nillius SJ
J Steroid Biochem; 1985 Nov; 23(5B):849-54. PubMed ID: 2934581
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effect of prolactin secretion by luteinizing hormone releasing hormone agonist (buserelin)].
Inoue T; Matsuoka R; Mori H; Kigawa T
Nihon Naibunpi Gakkai Zasshi; 1986 Jun; 62(6):745-53. PubMed ID: 3093292
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of cyclic attacks of acute intermittent porphyria with an LH-RH agonist administered by the intranasal route].
Semon C; Dupond JL; Mallet H; Grandmottet-Cambefort C; Humbert P
Ann Endocrinol (Paris); 1986; 47(5):399-402. PubMed ID: 3103522
[TBL] [Abstract][Full Text] [Related]
38. Hot flushes during Gn-RH analogue administration despite normal serum oestradiol levels.
Bider D; Ben-Rafael Z; Shalev J; Mashiach S; Serr DM; Blankstein J
Maturitas; 1989 Sep; 11(3):223-8. PubMed ID: 2512468
[TBL] [Abstract][Full Text] [Related]
39. [Change of gonadotropin release in follicular phase following several injections of a highly effective LH-RH-Analogue (HOE 766)].
Dericks-Tan JS; Renner A; Baumann R; Taubert HD
Arch Gynecol; 1979 Jul; 228(1-4):563-4. PubMed ID: 384927
[No Abstract] [Full Text] [Related]
40. Peptide contraception in women. Inhibition of ovulation by chronic intranasal LRH agonist therapy.
Bergquist C; Nillius SJ; Wide L
Ups J Med Sci; 1984; 89(2):99-106. PubMed ID: 6431676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
